We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+14.45%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.83B
AUM Growth
-$23.2M
Cap. Flow
-$201M
Cap. Flow %
-10.94%
Top 10 Hldgs %
24.61%
Holding
261
New
14
Increased
25
Reduced
199
Closed
13

Top Buys

Rank Stock Value
1
SRAD icon
Sportradar
SRAD
+$23.7M
2
FOUR icon
Shift4
FOUR
+$22.6M
3
PRGS icon
Progress Software
PRGS
+$9.32M
4
QDEL icon
QuidelOrtho
QDEL
+$7.08M
5
VRDN icon
Viridian Therapeutics
VRDN
+$6.06M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$58.7M
2
WNS
WNS Holdings
WNS
+$46.2M
3
TKO icon
TKO Group
TKO
+$23.8M
4
WLDN icon
Willdan Group
WLDN
+$8.81M
5
EEFT icon
Euronet Worldwide
EEFT
+$7.12M

Sector Composition

Rank Sector Weight
1 Healthcare 32.04%
2 Technology 28.06%
3 Industrials 18.08%
4 Consumer Discretionary 6.84%
5 Communication Services 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LKQ icon
26
LKQ Corp
LKQ
$6.29B
$20.4M 1.11%
667,838
-31,378
-4% -$1.03M
DOX icon
27
Amdocs
DOX
$6.22B
$19.6M 1.07%
239,287
-22,045
-8% -$1.91M
AGM icon
28
Federal Agricultural Mortgage
AGM
$2.56B
$18.5M 1.01%
110,094
-17,312
-14% -$3.24M
NGVT icon
29
Ingevity
NGVT
$2.68B
$18.4M 1.01%
334,042
-31,595
-9% -$1.64M
VRDN icon
30
Viridian Therapeutics
VRDN
$2.67B
$18.4M 1%
851,663
+336,040
+65% +$6.06M
ITRN icon
31
Ituran Location and Control
ITRN
$1.05B
$17.6M 0.96%
493,614
-15,001
-3% -$567K
MTN icon
32
Vail Resorts
MTN
$5.3B
$17.3M 0.94%
115,724
+11,809
+11% +$1.83M
RDWR icon
33
Radware
RDWR
$1.19B
$17.1M 0.93%
645,131
-109,004
-14% -$2.91M
MMS icon
34
Maximus
MMS
$3.1B
$16.7M 0.91%
183,239
-845
-0.5% -$68.5K
HROW icon
35
Harrow
HROW
$1.51B
$16.1M 0.88%
333,695
-36,932
-10% -$1.39M
NEXN
36
Nexxen International
NEXN
$607M
$16M 0.87%
1,730,381
+436,582
+34% +$4.33M
LMAT icon
37
LeMaitre Vascular
LMAT
$1.86B
$15.6M 0.85%
178,186
-35,684
-17% -$3.19M
PRGS icon
38
Progress Software
PRGS
$1.76B
$14.9M 0.81%
338,941
+202,305
+148% +$9.32M
CRAI icon
39
CRA International
CRAI
$1.06B
$14.8M 0.81%
71,032
-12,280
-15% -$2.36M
BCRX icon
40
BioCryst Pharmaceuticals
BCRX
$2.4B
$14.3M 0.78%
1,880,389
-179,891
-9% -$1.5M
SSTK icon
41
Shutterstock
SSTK
$219M
$14.2M 0.78%
681,731
-68,934
-9% -$1.4M
NBIX icon
42
Neurocrine Biosciences
NBIX
$16.6B
$14M 0.76%
99,465
-8,917
-8% -$1.21M
AEHR icon
43
Aehr Test Systems
AEHR
$3.36B
$13.4M 0.73%
444,381
-168,071
-27% -$3.64M
OZK icon
44
Bank OZK
OZK
$5.61B
$13.2M 0.72%
258,651
-22,362
-8% -$1.14M
ACAD icon
45
Acadia Pharmaceuticals
ACAD
$5.03B
$13.1M 0.72%
614,937
-54,869
-8% -$1.3M
LQDT icon
46
Liquidity Services
LQDT
$1.32B
$12.8M 0.7%
465,158
+135,204
+41% +$3.48M
MIRM icon
47
Mirum Pharmaceuticals
MIRM
$6.14B
$12.1M 0.66%
164,746
-67,247
-29% -$4.27M
GNTX icon
48
Gentex
GNTX
$5.07B
$11.7M 0.64%
412,003
-34,545
-8% -$918K
ALKS icon
49
Alkermes
ALKS
$8.25B
$11.6M 0.63%
385,342
-36,543
-9% -$1.03M
INSM icon
50
Insmed
INSM
$28.6B
$11.5M 0.63%
79,667
-7,103
-8% -$870K
1
2
3 4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Rice Hall James & Associates held 261 positions worth $1.83B, down 1.2% from $1.86B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $201M in Q3 2025, closing 13 positions and reducing 199 holdings. Its most notable exit was Olo Inc, an estimated $4.38M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Sportradar worth $21.5M.

  • Rice Hall James & Associates's largest Q3 2025 buy was Sportradar: 799,217 shares worth $21.5M.
  • Rice Hall James & Associates added most to Shift4 in Q3 2025, an estimated $22.6M increase.
  • Rice Hall James & Associates's biggest Q3 2025 reduction was Verona Pharma, cutting an estimated $58.7M.
  • Rice Hall James & Associates fully exited Olo Inc in Q3 2025, selling an estimated $4.38M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.83B portfolio in Q3 2025.
  • Rice Hall James & Associates opened 14 new positions and closed 13 in Q3 2025.
  • Rice Hall James & Associates's portfolio value fell 1.2% quarter-over-quarter to $1.83B.

Based on Rice Hall James & Associates's 13F filing for Q3 2025, filed 16 Oct 2025.